Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Raw Materials (2023)

Neuroone Medical Technologies' Raw Materials history spans 1 years, with the latest figure at $1.0 million for Q4 2023.

  • For Q4 2023, Raw Materials changed N/A year-over-year to $1.0 million; the TTM value through Dec 2023 reached $1.0 million, changed N/A, while the annual FY2023 figure was $1.2 million, N/A changed from the prior year.
  • Raw Materials reached $1.0 million in Q4 2023 per NMTC's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.2 million in Q3 2023 to a low of $1.0 million in Q4 2023.